Holly Schachner

Holly Schachner

Chief Tech/Sci/R&D Officer at
DoubleRainbow Biosciences, Inc.
59 year
Health Technology
Consumer Services
Commercial Services

Profile

Holly Schachner is Chief Medical Officer at DoubleRainbow Biosciences, Inc. since 2021.
Former roles include Lead Independent Director at Applied Molecular Transport, Inc. from 2022 to 2023, Senior Vice President-Clinical Science Therapeutic at MyoKardia, Inc. from 2020 to 2021, Chief Medical Officer-Global Specialty Medicine at Allergan UC from 2019 to 2020, and Head-Diabetes & Cardiovascular Business Unit at Sanofi from 2016 to 2019.
Education includes a doctorate from Stony Brook School and an undergraduate degree from the University of Michigan.

Holly Schachner active positions

CompaniesPositionStart
Chief Tech/Sci/R&D Officer 31/07/2021

Former positions of Holly Schachner

CompaniesPositionEnd
APPLIED MOLECULAR TRANSPORT INC. Director/Board Member 26/12/2023
MYOKARDIA, INC. Corporate Officer/Principal 31/03/2021
ALLERGAN PLC Corporate Officer/Principal 30/06/2020
SANOFI Corporate Officer/Principal 31/12/2018
See the detail of Holly Schachner's experience

Training of Holly Schachner

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

66

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Health Technology

Consumer Services

Health Technology

Consumer Services

Health Technology

Commercial Services

Health Technology

  1. Stock Market
  2. Insiders
  3. Holly Schachner
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!